REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL
Product details
Registration number: SIN16471P
Classification: Prescription Only
Active ingredients: Luspatercept
Strength: 75.0 MG/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: SUBCUTANEOUS
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
ATC code: B03XA06
HSA approval date: 6 April 2022
Manufacturer(s): Patheon Italia S.p.A.
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16471P
Classification: Prescription Only
What active ingredients and strength are recorded for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Luspatercept
Strength: 75.0 MG/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Patheon Italia S.p.A.
Manufacturing country/countries: ITALY
Where can I look up REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16471P or the exact product name REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL. The general register link does not preselect this product.
What are the source dates for this REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16471P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)